Acute in vivo antiarrhythmic effects of cGMP-modifying drugs in the R2474S mouse model of catecholiminergic polymorphic ventricular tachycardia.

Back

EHRA Premium Access

Acute in vivo antiarrhythmic effects of cGMP-modifying drugs in the R2474S mouse model of catecholiminergic polymorphic ventricular tachycardia.

Session: Basic science and arrhythmias (1)

Topic: Arrhythmias

Speaker: Doctor P. Tickle (Manchester, GB)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Peter Tickle

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Telomere length is associated with adverse atrial remodeling in patients with atrial fibrillation

Speaker: Professor M. Gramlich (Aachen, DE)

Histological validation of clinical classification models of atrial cardiomyopathy

Speaker: Doctor J. Winters (Maastricht, NL)

Transmurality of post-myocardial infarction scar and the cycle length of ventricular tachycardia

Speaker: Doctor M. Freeman (Glasgow, GB)

Etripamil - a multichannel modulator to suppress atrial fibrillation

Speaker: Mr M. Prueser (Heidelberg, DE)

Access the full session

Basic science and arrhythmias (1)

Speakers: Doctor P. Tickle, Professor M. Gramlich, Doctor J. Winters, Doctor M. Freeman, Mr M. Prueser

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources